Considering the role of azurocidin in infection and inflammatory reactions [12,13,14,15,16,17] and its ability to predict worse outcomes in sepsis and acute respiratory distress syndrome (ARDS) [15,16,20], this current study aimed to investigate its role in patients with STEMI. This evidence concerns the gene AZU1 and infection.